Evaluation of Clinical, Laboratory and Treatment Modalities in C3 Glomerulopathy: Single Center Experience Cover

.blurhash-client-img { display: none !important; }

Evaluation of Clinical, Laboratory and Treatment Modalities in C3 Glomerulopathy: Single Center Experience

Volume 40 (2019): Issue 2 (October 2019)

By: H. Hasan Yeter, Erdem Sütiçen, Berfu Korucu, Özant Helvaci, Burak Özbaş, İpek Gönül, Ülver Derici, Turgay Arinsoy and Galip Güz

Open Access

|Oct 2019

Authors

H. Hasan Yeter

hasanyeter@hotmail.com

Department of Nephrology, Gazi University, Ankara, Turkey

Erdem Sütiçen

Internal Medicine, Gazi University, Ankara, Turkey

Berfu Korucu

Department of Nephrology, Gazi University, Ankara, Turkey

Özant Helvaci

Department of Nephrology, Gazi University, Ankara, Turkey

Burak Özbaş

Department of Nephrology, Gazi University, Ankara, Turkey

İpek Gönül

Department of Pathology, Gazi University, Ankara, Turkey

Ülver Derici

Department of Nephrology, Gazi University, Ankara, Turkey

Turgay Arinsoy

Department of Nephrology, Gazi University, Ankara, Turkey

Galip Güz

Department of Nephrology, Gazi University, Ankara, Turkey

DOI: https://doi.org/10.2478/prilozi-2019-0010 | Journal eISSN: 1857-8985 | Journal ISSN: 1857-9345

Journal RSS Feed

Language: English

Page range: 15 - 23

Published on: Oct 11, 2019

Published by: Macedonian Academy of Sciences and Arts

In partnership with: Paradigm Publishing Services

Publication frequency: 2 issues per year

Keywords:

C3 glomerulopathy,

end stage renal disease,

mycophenolate mofetil

Related subjects:

Basic medical science,

History and ethics of medicine,

Clinical medicine,

Clinical medicine, other,

Social sciences,

Education, other

© 2019 H. Hasan Yeter, Erdem Sütiçen, Berfu Korucu, Özant Helvaci, Burak Özbaş, İpek Gönül, Ülver Derici, Turgay Arinsoy, Galip Güz, published by Macedonian Academy of Sciences and Arts
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.

Previous article Volume 40 (2019): Issue 2 (October 2019)Next article